site stats

Atara aktie

WebApr 6, 2024 · A high-level overview of Atara Biotherapeutics, Inc. (ATRA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Bayer and Atara Biotherapeutics Enter Strategic Collaboration for ...

WebAug 9, 2024 · Atara will host a live conference call and webcast today, Monday, August 9, 2024, at 4:30 p.m. EDT to discuss the Company’s financial results and recent operational highlights. WebApr 11, 2024 · Atara Biotherapeutics (ATRA) Reports Q4 Loss, Misses Revenue Estimates. Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -18.03% and … faroz velbert https://propupshopky.com

Atara Biotherapeutics Aktie - Dividende (2024 & historisch) Parqet

WebApr 10, 2024 · 10% most volatile stocks in US Market. 16.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week. Volatility Over Time: ATRA's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks. WebFeb 27, 2024 · Recently, Atara sold a redundant cell manufacturing facility to Fuji, which earned them $100mn in cash. A major recent news that crashed the stock was the death of a patient in its CAR-T program ... WebDec 7, 2024 · Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With our lead program in Phase 3 clinical development, Atara is the most advanced ... farpofa gyulladás

Atara Biotherapeutics, Inc. (ATRA) - Yahoo Finance

Category:Cell therapy company Atara sells Southern California …

Tags:Atara aktie

Atara aktie

Atara Biotherapeutics AKTIE Aktienkurs & News A1166A – …

WebNov 8, 2024 · About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With our lead program receiving a CHMP … WebGet the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

Atara aktie

Did you know?

WebApr 12, 2024 · Headline. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Short Interest Up 18.7% in March. marketbeat.com - March 31 at 7:40 AM. Short Interest in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Increases By 18.7%. americanbankingnews.com - April 1 at 9:30 AM. Atara Biotherapeutics (ATRA) Loses -33.02% in 4 Weeks, Here's … WebAtara Biotherapeutics Aktie 20 Jahre Umsatz, Dividende, Realtime-Kurs, EBIT, Gewinn, Ausschüttungsquote, Nettoverschuldung und die besten Aktienanalysen.

WebFeb 28, 2024 · Atara believes that its cash as of December 31, 2024, together with the anticipated $100.0 million payable to Atara upon closing of the strategic transaction with FDB, will be sufficient to fund ... WebApr 12, 2024 · Transcripts. CY 2024. Other Revised 03/09/23 Atara Biotherapeutics Inc at Cowen Health Care Conference 03/08/23 Other Revised 03/08/23 Atara Biotherapeutics Inc at HC Wainwright Cell Therapy Virtual Conference 02/28/23 Other Revised 01/12/23 Atara Biotherapeutics Inc at JPMorgan Healthcare Conference 01/11/23. CY 2024.

WebZacks. Atara Biotherapeutics, Inc. develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States. Its lead product … WebAnlagetrends zur Amphastar Pharmaceuticals Aktie Aktie - Wirtschaftssektor, Trends, und Unternehmen derselben Peer Group Anlagetrends zur Amphastar Pharmaceuticals Aktie TraderFox Home

WebNov 12, 2014 · En enkelt aktiehandel gjorde kortvartigt, at Atara Biotherapeutics blev 23.000 mia. kr. værd. fredag 30. december 2024 Log ind Log ud Køb Menu

WebApr 11, 2024 · SAN DIEGO, April 11, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced that Kristin Yarema, Ph.D., has joined the Company as President, Cell Therapy effective today. "Kristin brings … farq1801azWebJan 10, 2024 · About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for ... hodedah long standing kitchen cabinetWebJan 27, 2024 · Atara Biotherapeutics, a California-based developer of cell therapies, will sell a large factory it built there to a contract manufacturing division of Japan's Fujifilm, announcing Wednesday a $100 million deal with Fujifilm Diosynth Biotechnologies. The facility, which encompasses 90,000 square feet in Thousand Oaks, California, was once … hodedah metal twinWebWerbung Atara Biotherapeutics-Aktie für 0 Euro handeln bei finanzen.net zero 07.11.22 finanzen.net Ausblick: Atara Biotherapeutics öffnet die Bücher zum abgelaufenen Quartal hodedah pantryWebVärde för Atara Biotherapeutics Inc (symbol: ATRA) i realtid, tekniska analyser, investering, värde och information om finansmarknad från Capital. ... Resultat per aktie efter utspädning exklusive extraordinära poster -0.85653-0.90929-0.90451-0.95795-0.8747: Dividends per Share - Common Stock Primary Issue 0: 0: 0: 0: hodedah partsWebFeb 9, 2024 · Atara is a cell therapy focused biotech with a unique approach based on a novel allogeneic Epstein-Barr virus (EBV) T-cell platform. The company secured the first ever approval of an allogeneic ... hodedah modern kitchen cabinet manualWebATARA BIOTHERAPEUTICS AKTIE Schätzungen Prognosen & Erwartungen A1166A. Tesla A1CX3T Deutsche Bank 514000 BASF BASF11 TUI TUAG50 Volkswagen (VW) … hodedah pink desk